Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

Author information

  • 1Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston, MA 02114, USA.

Abstract

OBJECTIVE:

To evaluate the scope of the available therapeutic armamentarium in attention-deficit hyperactivity disorder (ADHD).

METHOD:

The literature of medication trials in ADHD was systematically reviewed, with attention to issues of psychiatric comorbidity, age, gender, and ethnic background.

RESULTS:

One hundred fifty-five controlled studies of 5,768 children, adolescents, and adults have documented the efficacy of stimulants in an estimated 70% of subjects. The literature clearly documents that stimulants not only improve abnormal behaviors of ADHD, but also self-esteem, cognition, and social and family function. However, response varied in different age groups and with certain comorbid conditions. In addition, there is an impressive body of literature documenting the efficacy of tricyclic antidepressants on ADHD in more than 1,000 subjects. Studies of alternative antidepressants, antipsychotics, antihypertensives, and other compounds were also reviewed.

CONCLUSIONS:

The available literature indicates the important role of psychopharmacological agents in the reduction of the core symptoms of ADHD and associated impairments. More research is needed on alternative pharmacological treatments and to further evaluate established therapeutics beyond school-age Caucasian boys. In addition, more research is needed on the efficacy of treatment for comorbid ADHD, use of combined medications, and the combination of medication and psychosocial treatment.

Comment in

  • Responders and nonresponders. [J Am Acad Child Adolesc Psychiatry. 1996]
  • Alternative medications for ADHD. [J Am Acad Child Adolesc Psychiatry. 1997]
PMID:
8919704
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk